Overview
The staff within the Gene Transfer, Targeting and Therapeutics Viral Vector Core provide expert consultation for the safe and effective use of viral vector technologies, and offer custom design and production services for multiple viral vector types. The Gene Transfer, Targeting and Therapeutics Viral Vector Core facilitates the use of these powerful research tools by Salk researchers and others across diverse fields of study such as systems neuroscience, stem cell biology, metabolism, ageing, cancer biology and gene therapy.
Due to recent changes in the Export Administration Regulations regarding rabies vectors, we are unable to distribute outside of the United States any reagents (viral vectors, plasmids, or cell lines) that contain any portion of the rabies genome.
National Cancer Institute
National Eye Institute
National Institute of Neurological Disorders and Stroke
The GT3 core is a designated Cancer Center Council (C3) core facility. Cancer Center members from participating C3 institutes have preferential rates.
For submitting manuscripts that have made use of services or resources from this core, PLEASE ACKNOWLDGE SUPPORT by inclusion of the following information:
“This work was supported by the GT3 Core Facility of the Salk Institute with funding from NIH-NCI CCSG: P30 CA01495, an NINDS R24 Core Grant and funding from NEI” Please acknowledge core staff where appropriate and consider authorship inclusion when scientific contributions merit.
Please link each publication stemming from work performed in the core to your MyNCBI account. This will ensure that the contributions from NIH are appropriately acknowledged in renewal and continuation applications. This NIH requirement must be satisfied as part of our efforts to provide consistent access to stabling funded core resources. Information on how to link publications can be found here»
Research reported was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R24NS092943. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
10010 N Torrey Pines Rd
La Jolla, CA 92037
Telephone: (858) 453-4100
Telephone:
(858) 453-4100 ext. 1891 (Director)
(858) 453-4100 ext. 1242 (Lab - Core Staff)
E-mail: GT3@salk.edu (For ordering information and request submission).
Mailing Address:
Salk Institute, GT3
10010 N Torrey Pines Rd
La Jolla, CA 92037-1099
Our offices are located just North of the Salk Institute in the Sanford Consortium for Regenerative Medicine building.
Office Location
Room 1318
Lab Location
Room 1106
Your partnership allows our scientists to accelerate the pace of high-risk, high-reward discoveries that have the potential to benefit the health of all humanity-be it cancer, Alzheimer’s disease, climate change, infectious diseases or more.
